Ma, Liu
Dou, Lizhou
Liu, Yong
Zhang, Yueming
Liu, Xudong
Ng, Hoi-loi
Chu, Jiangtao
Liu, Yumeng
Li, Zhengqi
Ke, Yan
Liu, Siyao
He, Shun
Wang, Guiqi
Funding for this research was provided by:
Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2024-JKCS-30)
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2022B05, LC2022B35)
CAMS Innovation Fund for Medical Sciences (2021-I2M-1-013, 2021-I2M-1-015, 2021-I2M-1-061)
National High Level Hospital Clinical Research Funding (80102022514)
Article History
Received: 12 May 2025
Accepted: 13 September 2025
First Online: 14 October 2025
Declarations
:
: This study was approved by the Ethics Committee of the National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (Approval Number: 21/249–2920). All the participants provided written informed consent.
: Not applicable.
: The authors declare no competing interests.